Textbooks
Briggs, Sculpher, Claxton: Decision Modelling for Health Economic Evaluation, Oxford University Press
Kleinbaum and Klein. Survival analysis: A self-learining text 3rd ed. Springer
Hunink, Glasziou, Siegel, Weeks, Pliskin, Elstein, Weinstein: Decision Making in health and medicine – Integrating evidence and values. Cambridge, Cambridge University Press, 2001. ISBN 0 521 77029 7
Online Research Papers
Sullivan, SD,.JA. Mauskopf,F Augustovski, JJ Caro, KM. Lee, M Minchin, E Orlewska, P Penna, JMR Barrios, WY Shau (2014). Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value in Health (5-14) http://dx.doi.org/10.1016/j.jval.2013.08.2291
Eddy, DM, W Hollingworth, JJ Caro, J Tsevat, KM. McDonald, JB. Wong, on Behalf of the ISPOR?SMDM Modeling Good Research Practices Task Force (2012). Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Value in Health 15. 843-850 https://doi.org/10.1177/0272989X12454579
Sanders, GD, PJ. Neumann, A Basu, DW. Brock, D Feeny, M Krahn, KM. Kuntz, DO. Meltzer, DK. Owens, LA. Prosser, JA. Salomon, MJ. Sculpher, TA. Trikalinos, LB. Russell, JE. Siegel, TG. Ganiats,(2016). Recommendations for Conduct,Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine. JAMA. 2016;316(10):1093-1103. https://doi.org/10.1001/jama.2016.12195
Grutters, JPC, M Sculpher, AH. Briggs, JL. Severens, MJ. Candel, JE. Stahl, DD Ruysscher, A Boer, BLT, Ramaekers, MA. Joore (2013). Acknowledging Patient Heterogeneity in Economic Evaluation A Systematic Literature Review. PharmacoEcnomics 31:111-123 https://doi.org/10.1007/s40273-012-0015-4
Calibration/Validation
Vanni T, Karnon J, Madan J, White RG, Edmunds WJ, Foss A, Legood R. Calibrating models in economic evaluation: A seven-step approach. Pharmacoeconomics 2011 ;29 :35-49
Stout NK, Knudsen AB, Chung YK, McMahon PM, Gazelle GS. Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics 2009;27:533-545.
Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–7. Medical Decision Making. 2012 Sep;32(5):733-43.
Dynamic
Brennan A, Chick SE, Davies R (2006) A taxonomy of model structures for economic evaluation of health technologies. Health Economics 15: 1295-1310.
Rutter CM, Zaslavsky AM, Feuer EJ. Dynamic microsimulation models for health outcomes: a review. Medical Decision Making 2011;31:10-18.
Edmunds WJ, Medley GF, Nokes DJ. Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Statistics in Medicine 1999;18:3263-3282.
Brisson M, Edmunds WJ. Impact of model, methological, and parameter uncertainty in the economic analysis of vaccination programs. Medical Decision Making 2006;26:434-446.
Here's one on determining transition probabilities (a topic potentially for an earlier class):
Miller DK, Homan SM. Determining transition probabilities: confusion and suggestions. Medical Decision Making 1994;14:52-58.